Rapid Micro Biosystems stockholders elect Richard Kollender as Class II director, ratify PwC as auditor

RAPID MICRO BIOSYSTEMS, INC.

Richard Kollender re-elected as Class II Director with 23,180,585 votes for, 1,998,525 withheld, 11,920,445 broker non-votes.
Shareholders ratified PricewaterhouseCoopers LLP as independent auditor for FY2026: 37,096,030 for, 3,292 against, 233 abstaining.
Both proposals passed; no other matters were voted on at the annual meeting.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

RAPID MICRO BIOSYSTEMS, INC. shareholders approved Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year 2026 at the 2026-05-21 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-05-21

Exact text from the filing

The Company’s stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

RAPID MICRO BIOSYSTEMS, INC. shareholders approved Election of Richard Kollender as Class II Director at the 2026-05-21 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-05-21

Exact text from the filing

The Company’s stockholders elected Richard Kollender as a Class II Director to serve until the 2029 Annual Meeting of Stockholders and until his successor has been duly elected and qualified or until such director’s earlier death, resignation or removal.

View on SEC.gov

Browse all shareholder votes →

RAPID MICRO BIOSYSTEMS, INC. filing history →

Source: SEC EDGAR

accession 0001380106-26-000085

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.